199 related articles for article (PubMed ID: 37735239)
1. Continuous directed evolution of a compact CjCas9 variant with broad PAM compatibility.
Schmidheini L; Mathis N; Marquart KF; Rothgangl T; Kissling L; Böck D; Chanez C; Wang JP; Jinek M; Schwank G
Nat Chem Biol; 2024 Mar; 20(3):333-343. PubMed ID: 37735239
[TBL] [Abstract][Full Text] [Related]
2. Improving Plant Genome Editing with High-Fidelity xCas9 and Non-canonical PAM-Targeting Cas9-NG.
Zhong Z; Sretenovic S; Ren Q; Yang L; Bao Y; Qi C; Yuan M; He Y; Liu S; Liu X; Wang J; Huang L; Wang Y; Baby D; Wang D; Zhang T; Qi Y; Zhang Y
Mol Plant; 2019 Jul; 12(7):1027-1036. PubMed ID: 30928637
[TBL] [Abstract][Full Text] [Related]
3. High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMs.
Huang TP; Heins ZJ; Miller SM; Wong BG; Balivada PA; Wang T; Khalil AS; Liu DR
Nat Biotechnol; 2023 Jan; 41(1):96-107. PubMed ID: 36076084
[TBL] [Abstract][Full Text] [Related]
4. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
5. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
[TBL] [Abstract][Full Text] [Related]
6. Engineered Campylobacter jejuni Cas9 variant with enhanced activity and broader targeting range.
Nakagawa R; Ishiguro S; Okazaki S; Mori H; Tanaka M; Aburatani H; Yachie N; Nishimasu H; Nureki O
Commun Biol; 2022 Mar; 5(1):211. PubMed ID: 35260779
[TBL] [Abstract][Full Text] [Related]
7. Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences.
Hua K; Tao X; Han P; Wang R; Zhu JK
Mol Plant; 2019 Jul; 12(7):1003-1014. PubMed ID: 30928636
[TBL] [Abstract][Full Text] [Related]
8. Compact Cje3Cas9 for Efficient
Chen S; Liu Z; Xie W; Yu H; Lai L; Li Z
CRISPR J; 2022 Jun; 5(3):472-486. PubMed ID: 35686977
[TBL] [Abstract][Full Text] [Related]
9. Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery.
Kweon J; Jang AH; Kwon E; Kim U; Shin HR; See J; Jang G; Lee C; Koo T; Kim S; Kim Y
Exp Mol Med; 2023 Feb; 55(2):377-384. PubMed ID: 36720917
[TBL] [Abstract][Full Text] [Related]
10. Continuous evolution of SpCas9 variants compatible with non-G PAMs.
Miller SM; Wang T; Randolph PB; Arbab M; Shen MW; Huang TP; Matuszek Z; Newby GA; Rees HA; Liu DR
Nat Biotechnol; 2020 Apr; 38(4):471-481. PubMed ID: 32042170
[TBL] [Abstract][Full Text] [Related]
11. The SpRY Cas9 variant release the PAM sequence constraint for genome editing in the model plant Physcomitrium patens.
Calbry J; Goudounet G; Charlot F; Guyon-Debast A; Perroud PF; Nogué F
Transgenic Res; 2024 Apr; 33(1-2):67-74. PubMed ID: 38573428
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
[TBL] [Abstract][Full Text] [Related]
13. Expanding the scope of CRISPR/Cas9-mediated genome editing in plants using an xCas9 and Cas9-NG hybrid.
Niu Q; Wu S; Li Y; Yang X; Liu P; Xu Y; Lang Z
J Integr Plant Biol; 2020 Apr; 62(4):398-402. PubMed ID: 31702097
[TBL] [Abstract][Full Text] [Related]
14. SpRY Cas9 Can Utilize a Variety of Protospacer Adjacent Motif Site Sequences To Edit the Candida albicans Genome.
Evans BA; Bernstein DA
mSphere; 2021 May; 6(3):. PubMed ID: 34011687
[No Abstract] [Full Text] [Related]
15. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
[TBL] [Abstract][Full Text] [Related]
16. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants.
Zhang W; Yin J; Zhang-Ding Z; Xin C; Liu M; Wang Y; Ai C; Hu J
Nucleic Acids Res; 2021 Sep; 49(15):8785-8795. PubMed ID: 34133740
[TBL] [Abstract][Full Text] [Related]
17. Editing Properties of Base Editors with SpCas9-NG in Discarded Human Tripronuclear Zygotes.
Liu X; Zhou X; Li G; Huang S; Sun W; Sun Q; Li L; Huang X; Liu J; Wang L
CRISPR J; 2021 Oct; 4(5):710-727. PubMed ID: 34661426
[TBL] [Abstract][Full Text] [Related]
18. Genome editing with natural and engineered CjCas9 orthologs.
Gao S; Wang Y; Qi T; Wei J; Hu Z; Liu J; Sun S; Liu H; Wang Y
Mol Ther; 2023 Apr; 31(4):1177-1187. PubMed ID: 36733251
[TBL] [Abstract][Full Text] [Related]
19. Highly efficient base editing with expanded targeting scope using SpCas9-NG in rabbits.
Liu Z; Shan H; Chen S; Chen M; Song Y; Lai L; Li Z
FASEB J; 2020 Jan; 34(1):588-596. PubMed ID: 31914687
[TBL] [Abstract][Full Text] [Related]
20. Genome editing mediated by SpCas9 variants with broad non-canonical PAM compatibility in plants.
Li J; Xu R; Qin R; Liu X; Kong F; Wei P
Mol Plant; 2021 Feb; 14(2):352-360. PubMed ID: 33383203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
